Substituted ketoxime benzoylamides

US10785979B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10785979-B2
Application numberUS-201615754313-A
CountryUS
Kind codeB2
Filing dateAug 22, 2016
Priority dateAug 25, 2015
Publication dateSep 29, 2020
Grant dateSep 29, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In this formula (I), R1′, R2′, X, Y and W are radicals such as hydrogen, organic radicals such as alkyl, and other radicals such as halogen. Q is an oxadiazole, tetrazole or triazole radical.

First claim

Opening claim text (preview).

The invention claimed is: 1. A substituted ketoxime benzoylamide of formula (I) in which Q is a Q1, Q2, Q3 or Q4 radical R is hydrogen, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, halo-(C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, R 1 (O)C—(C 1 -C 6 )-alkyl, R 1 O(O)C—(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O)C—(C 1 -C 6 )-alkyl, NC—(C 1 -C 6 )-alkyl, R 1 O—(C 1 -C 6 )-alkyl, R 1 (O)CO—(C 1 -C 6 )-alkyl, R 1 O(O)C—O—(C 1 -C 6 )-alkyloxy, R 2 (O) 2 SO—(C 1 -C 6 )-alkyl, (R 1 ) 2 N—(C 1 -C 6 )-alkyl, R 1 (O)C(R 1 )N—(C 1 -C 6 )-alkyl, R 2 (O) 2 S(R)N—(C 1 -C 6 )-alkyl, R 2 (O) n S—(C 1 -C 6 )-alkyl, R 1 O(O) 2 S—(C 1 -C 6 )-alkyl, (R 1 ) 2 N(O) 2 S—(C 1 -C 6 )-alkyl, R 1 (O)C, R 1 O(O)C, (R 1 ) 2 N(O)C, R 10 , (R 1 ) 2 N, R 1 O(O)C(R 1 )N, (R 1 ) 2 N(O)C(R 1 )N, R 2 (O) 2 S, or benzyl substituted in each case by s radicals selected from the group consisting of methyl, ethyl, methoxy, nitro, trifluoromethyl and halogen, R 1 is hydrogen, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkenyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O—(C 1 -C 6 )-alkyl, cycloalkyl-(C 1 -C 6 )-alkyl-O—(C 1 -C 6 )-alkyl, phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl, heterocyclyl-(C 1 -C 6 )-alkyl, phenyl-O—(C 1 -C 6 )-alkyl, heteroaryl-O—(C 1 -C 6 )-alkyl, heterocyclyl-O—(C 1 -C 6 )-alkyl, phenyl-N(R 3 )—(C 1 -C 6 )-alkyl, heteroaryl-N(R 3 )—(C 1 -C 6 )-alkyl, heterocyclyl-N(R 3 )—(C 1 -C 6 )-alkyl, phenyl-S(O) n —(C 1 -C 6 )-alkyl, heteroaryl-S(O) n —(C 1 -C 6 )-alkyl or heterocyclyl-S(O) n —(C 1 -C 6 )-alkyl, where the fifteen latter radicals are each substituted by s radicals selected from the group consisting of nitro, halogen, cyano, thiocyanato, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, R 3 O(O)C, (R 3 ) 2 N(O)C, R 3 O, (R 3 ) 2 N, R 4 (O) n S, R 3 O(O) 2 S, (R 3 ) 2 N(O) 2 S and R 3 O—(C 1 -C 6 )-alkyl, and where heterocyclyl bears n oxo groups, R 2 is (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkenyl, halo-(C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O—(C 1 -C 6 )-alkyl, cycloalkyl-(C 1 -C 6 )-alkyl-O—(C 1 -C 6 )-alkyl, phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, heteroaryl-(C 1 -C 6 )-alkyl, heterocyclyl, heterocyclyl-(C 1 -C 6 )-alkyl, phenyl-O—(C 1 -C 6 )-alkyl, heteroaryl-O—(C 1 -C 6 )-alkyl, heterocyclyl-O—(C 1 -C 6 )-alkyl, phenyl-N(R 3 )—(C 1 -C 6 )-alkyl, heteroaryl-N(R 3 )—(C 1 -C 6 )-alkyl, heterocyclyl-N(R 3 )—(C 1 -C 6 )-alkyl, phenyl-S(O) n —(C 1 -C 6 )-alkyl, heteroaryl-S(O) n —(C 1 -C 6 )-alkyl or heterocyclyl-S(O) n —(C 1 -C 6 )-alkyl, where the fifteen latter radicals are each substituted by s radicals selected from the group consisting of nitro, halogen, cyano, thiocyanato, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, R 3 O(O)C, (R 3 ) 2 N(O)C, R 3 O, (R 3 ) 2 N, R 4 (O) n S, R 3 O(O) 2 S, (R 3 ) 2 N(O) 2 S and R 3 O—(C 1 -C 6 )-alkyl, and where heterocyclyl bears n oxo groups, R 3 is hydrogen, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl or phenyl, R 4 is (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl or phenyl, R 5 is hydrogen or (C 1 -C 4 )-alkyl, R 6 is (C 1 -C 4 )-alkyl, R 7 is acetoxy, acetamido, N-methylacetamido, benzoyloxy, benzamido, N-methyl-benzamido, methoxycarbonyl, ethoxycarbonyl, benzoyl, methylcarbonyl, piperidinylcarbonyl, morpholinylcarbonyl, trifluoromethylcarbonyl, aminocarbonyl, methylaminocarbonyl, dimethylaminocarbonyl, methylsulfenyl, methylsulfinyl, methylsulfonyl, (C 3 -C 6 )-cycloalkyl, or heteroaryl or heterocyclyl each substituted by s radicals selected from the group consisting of methyl, ethyl, methoxy, trifluoromethyl and halogen, R 8 is (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl-O—(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl or (C 3 -C 6 )-alkynyl, R 9 is (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl or (C 3 -C 6 )-alkynyl, R 10 is hydrogen, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl or (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, R 11 is (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl or (C 2 -C 6 )-alkynyl, R 1′ is cyano, (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, halo-(C 1 -C 6 )-alkyl, OR 8 , SR 8 , or NR 8 R 9 , R 2′ is hydrogen, (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-cycloalkenyl, or (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl, where the last six radicals are each substituted by s radicals selected from the group consisting of cyano, halogen, nitro, thiocyanato, OR 10 , S(O) n R 11 , N(R 10 ) 2 , NR 10 OR 10 , COR 10 , OCOR 10 , SCOR 11 , NR 10 COR 10 , NR 10 SO 2 R 11 , CO 2 R 10 , COSR 11 , CON(R 10 ) 2 and (C 1 -C 4 )-alkoxy-(C 2 -C 6 )-alkoxycarbonyl; or is phenyl, phenyl-(C 1 -C 6 )-alkyl, heteroaryl, (C 1 -C 6 )-alkylheteroaryl, heterocyclyl, (C 1 -C 6 )-alkylheterocyclyl, (C 1 -C 6 )-alkyl-O-heteroaryl, (C 1 -C 6 )-alkyl-O-heterocyclyl, (C 1 -C 6 )-alkyl-NR 10 - heteroaryl, or (C 1 -C 6 )-alkyl-NR 10 -heterocyclyl, where the ten latter radicals are each substituted by s radicals selected from the group consisting of cyano, halogen, nitro, thiocyanato, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, OR 10 , S(O) n R 11 , N(R 10 ) 2 , NR 10 OR 10 , COR 10 , OCOR 10 , SCOR 11 , NR 10 COR 10 , NR 10 SO 2 R 11 , CO 2 R 10 , COSR 11 , CON(R 10 ) 2 and (C 1 -C 4 )-alkoxy-(C 2 -C 6 )-alkoxycarbonyl, and where heterocyclyl bears n oxo groups, R X is (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, or halo-(C 3 -C 6 )-alkynyl, where the six aforementioned radicals are each substituted by s radicals selected from the group consisting of nitro, cyano, (R 6 ) 3 Si, (R 5 O) 2 (O)P, R 2 (O) n S, (R 1 ) 2 N, R 1 O, R 1 (O)C, R 1 O(O)C, R 1 (O)CO, R 2 O(O)CO, R 1 (O)C(R 1 )N, R 2 (O) 2 S(R 1 )N, (C 3 -C 6 )-cycloalkyl, heteroaryl, heterocyclyl and phenyl, where the four latter radicals themselves are in turn substituted by s radicals selected from the group consisting of (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkoxy, halo-(C 1 -C 6 )-alkoxy and halogen, and where heterocyclyl bears n oxo groups; or is (C 3 -C 7 )-cycloalkyl, heteroaryl, heterocyclyl or phenyl, where the four aforementioned radicals are each substituted by s radicals selected from the group consisting of halogen, nitro, cyano, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 6 )-alkyl-S(O) n , (C 1 -C 6 )-alkoxy, halo-(C 1 -C 6 )-alkoxy and (C 1 -C 6 )-alkoxy-(C 1 -C 4 )-alkyl, R Y is hydrogen, (C 1 -C 6 )-alkyl, halo-(C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, halo-(C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, halo-(C 3 -C 6 )-alkynyl, (C 3 -C 7 )-cycloalkyl, (C 1 -C 6 )-alkoxy, halo-(C 1 -C 6 )-alkoxy, (C 2 -C 6 )-alkenyloxy, (C 2 -C 6 )-alkynyloxy, cyano, nitro, methylsulfenyl, methylsulfinyl, methylsulfony

Assignees

Inventors

Classifications

  • C07D249/14Primary

    Nitrogen atoms · CPC title

  • 1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles · CPC title

  • 1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles · CPC title

  • with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical · CPC title

  • 1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10785979B2 cover?
In this formula (I), R1′, R2′, X, Y and W are radicals such as hydrogen, organic radicals such as alkyl, and other radicals such as halogen. Q is an oxadiazole, tetrazole or triazole radical.
Who is the assignee on this patent?
Bayer Cropscience Ag
What technology area does this patent fall under?
Primary CPC classification C07D249/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).